Form 8-K - Current report:
SEC Accession No. 0001104659-24-106432
Filing Date
2024-10-07
Accepted
2024-10-07 07:00:27
Documents
13
Period of Report
2024-10-07
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2419098d1_8k.htm   iXBRL 8-K 28884
  Complete submission text file 0001104659-24-106432.txt   202175

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA regn-20241007.xsd EX-101.SCH 3018
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE regn-20241007_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE regn-20241007_pre.xml EX-101.PRE 22361
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2419098d1_8k_htm.xml XML 3593
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

EIN.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 241356136
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)